Stock market news live updates: Stocks rally in final days of 2022 – Yahoo Finance

U.S. stocks charged higher Thursday, led by a rebound across technology stocks, as investors attempted to salvage the last two trading days of a brutal year for markets.
The S&P 500 (^GSPC) gained 1.7%, snapping two days of losses, while the Dow Jones Industrial Average (^DJI) jumped nearly 350 points, or 1.1%. The technology-heavy Nasdaq Composite (^IXIC) surged 2.6%. The moves come after all three major averages erased more than 1% in the previous trading session.
Megacap tech giants Apple (AAPL), Amazon (AMZN), and Alphabet (GOOG, GOOGL) all gained 2.8%, helping lift the broader market after a sell-off over the past two days. The risk-off trade this week saw Apple fall below $130, which investors have flagged as a key technical level. Meanwhile, Amazon become the third of FAANG+ stocks — along with Meta (META) and Netflix (NFLX) — to erase its pandemic gains and close below its March 2020 COVID crash low on Tuesday.
Netflix (NFLX) rallied 5.1%, rising from a seven-week low, on the heels of a two-step upgrade by CFRA analyst Kenneth Leon to Buy from Sell.
Investors continued to watch a rebound in Tesla (TSLA) after the stock snapped a seven-day losing streak Wednesday after a multi-session selling spree over concerns around the shutdown at its factory in China. Shares rose 8.1% Thursday.
Electric vehicle peers Rivian (RIVN), Lucid (LCID), and Nio (NIO) all recovered alongside Tesla after electric carmakers were under pressure all week.
Cal-Maine Foods (CALM) shares sank 14.5%, even as the egg producer reported fiscal second-quarter earnings beat analyst estimates, with revenue jumping 110% over last year as inflation and the bird flu pushed up egg prices.
Elsewhere on Thursday, biotech company Kala Pharmaceuticals (KALA) spiked 99%, extending a surge after the stock quadrupled Wednesday following the Food and Drug Administration's acceptance of the company’s investigational new drug application for treatment of a rare eye disease.
On the economic data front, filings for unemployment insurance rose to 225,000 in the week ended Dec. 24. from the prior week's reading of 216,000, the Labor Department said Thursday. The print came in on part with consensus estimates from economists surveyed by Bloomberg.
In other markets, oil extended a drop after its recent rally, with West Texas Intermediate (WTI) crude futures — the U.S. benchmark — settling at $78.39 on Thursday.
U.S. Treasury yields dipped, and the U.S. dollar index also retreated.
Selling pressures across December spurred by concerns around rising interest rates and a looming economic downturn have continued into the end of the month and thrown a wrench into the seasonal year-end rally that typically occurs in the final trading days of the year.
"Many factors historically have driven the traditional environment supportive of year-end stock rallies, such as the investing of holiday bonuses, a seasonal optimism among consumers and investors, and tax considerations," AXS Investments CEO Greg Bassuk said in a note. "However, with 2022’s dismal stock and bond performance expected to carry into 2023, along with ongoing inflationary concerns, uncertain Fed policy, and lingering geopolitical tensions, investors won’t be receiving any holiday gifts this year for their portfolios."
U.S. and global stocks remain on pace for their worst drop since the 2008 financial crisis.
—
Alexandra Semenova is a reporter for Yahoo Finance. Follow her on Twitter @alexandraandnyc
Click here for the latest trending stock tickers of the Yahoo Finance platform
Click here for the latest stock market news and in-depth analysis, including events that move stocks
Read the latest financial and business news from Yahoo Finance
Download the Yahoo Finance app for Apple or Android
Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube
Related Quotes
Yahoo Finance's Jared Blikre looks at how markets settled on Thursday afternoon.
U.S. stock indexes finish sharply higher on Thursday, the second-to-last trading session of the year, with the Nasdaq Composite jumping 2.6%, erasing losses from earlier in the week.
Hershey Co has been sued by a consumer who accused the company of selling dark chocolate that contains harmful levels of lead and cadmium. In a proposed class action filed on Wednesday, Christopher Lazazzaro said he would not have bought or would have paid less for Hershey's Special Dark Mildly Sweet Chocolate, Lily's Extra Dark Chocolate 70% Cocoa and Lily's Extreme Dark Chocolate 85% Cocoa had Hershey disclosed their metals content. Hershey did not immediately respond on Thursday to requests for comment on the lawsuit, which was filed in the federal court in Central Islip, New York.
A group of FTX customers from outside the United States have asked a U.S. bankruptcy judge to keep their names secret during the cryptocurrency exchange's bankruptcy case, saying that revealing their identities could expose them to identity theft and other scams. Bankrupt companies typically reveal the names and amounts of debt held by their creditors, including individual customers. But in a late Wednesday night court filing, a group of non-U.S. FTX customers who say they are owed $1.9 billion told U.S. Bankruptcy Judge John Dorsey that this case is different.
The Dow Jones rallied Thursday after first-time jobless claims. Tesla stock raced higher on a reiterated overweight rating.
Wheels Up, a private jet charter company, hasn't been shielded from this week's air travel chaos, Wheels Up Chairman and CEO Kenny Dichter told Yahoo Finance Live this week.
Goldman Sachs is preparing to trim its workforce in the coming weeks, Chief Executive Officer David Solomon told staff in a year-end audio message.
A Tesla bull tries to be a hero on the plunging stock price.
Simplify Asset Management Chief Strategist and Portfolio Manager Michael Green and Heritage Capital President Paul Schatz join Yahoo Finance Live to weigh in on the state of the markets, the odds of a recession, and what to expect from markets in 2023.
Business magnate Warren Buffett is widely regarded as one of the greatest investors of the modern-day world. His seemingly unmatched and consistent value-investing strategies have earned him the title of Oracle of Omaha. Many of his investing strategies are known, but there is one that is often overlooked yet incredibly important. It’s a lot more prevalent in the startup investing world — one customer can mean all the difference for a startup but not necessarily for public companies. What happen
The fallout from higher prices transformed the landscape for older Americans and those saving for their golden years.
What to watch in markets on Thursday, December 29, 2022.
The rate on the 30-year fixed mortgage rose to 6.42% from 6.27% the week prior, according to Freddie Mac.
Pelé, Brazil's mighty king of soccer, has died. He was 82. Since 2021, he had been undergoing treatment for colon cancer discovered during a routine medical exam. (Copyright 2022 The Associated Press.)
There’s been a lot of talk about the downward economic pressures that have pummeled the markets in 2022 – maybe too much such talk. Yes, the S&P 500 is down almost 21%, and the NASDAQ is down 35%, but investors can still find sound opportunities. J.P. Morgan analyst Ryan Brinkman has been sorting through the automotive industry stocks, and he’s found several that are worth a closer look. So let’s do just that. We know that the auto industry has its own particular headwinds, including the ongoing
Ukrainian President Volodymyr Zelensky and BlackRock CEO Larry Fink have formed an alliance to coordinate investments in rebuilding Ukraine, an official announcement from Zelensky’s office published Wednesday indicated.
Amazon is one bruised big-cap tech stock worth a look, says this longtime analyst.
Yahoo Finance Live look to Tesla's recent stock actions following a newly announced tax credit for EV owners in 2023.
It’s a big day for shareholders of tiny Kala Pharmaceuticals. The biotech company, which aims to treat rare diseases of the eye, said Tuesday that the Food and Drug Administration has accepted the company’s investigational new drug application for its lead drug candidate, known as KPI-012. That means the company can start a fresh clinical trial early next year for the drug candidate, which aims to treat a disease called persistent corneal epithelial defect. Kala shares more than tripled in Wedne
More than 300,000 U.S. accountants and auditors have left their jobs in the past two years, a 17% decline, and the dwindling number of college students coming into the field can’t fill the gap. Young professionals in the 25- to 34-year-old range and midcareer professionals between the ages of 45 and 54 also departed in high numbers starting in 2019, according to the Bureau of Labor Statistics. The huge gap between companies that need accountants and trained professionals has led to salary bumps and more temporary workers joining the sector.

source